SET and MYND domain-containing protein 2 (SMYD2): A prognostic biomarker associated with immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma

The histone lysine methyltransferase SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domain-containing protein (SMYD2) plays a role in the tumorigenesis of cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). However, the prognostic si...

Descripción completa

Detalles Bibliográficos

Autores principales:	An Zhanglu, Cai Danyang, Lin Xiongzhi, Xu Shuaijun, Bin Jin, Jin Xiaojun
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	University of Belgrade, University of Novi Sad 2022-01-01
Colección:	Archives of Biological Sciences
Materias:	cervical squamous cell carcinoma and endocervical adenocarcinoma(cesc) smyd2 immune infiltration
Acceso en línea:	http://www.doiserbia.nb.rs/img/doi/0354-4664/2022/0354-46642200014A.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!